Advertisement
Screener

IQVIA HOLDINGS INC. (IQV) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

IQVIA HOLDINGS INC. Stock-Based Compensation

IQVIA HOLDINGS INC. (IQV) reported Stock-Based Compensation of $65.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-05-05

  • IQVIA HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $65.00M, a 9.72% decline year-over-year.
  • IQVIA HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $60.00M, a 25.00% increase year-over-year.
  • IQVIA HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $55.00M, a 1.85% increase year-over-year.
  • IQVIA HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $60.00M, a 25.00% increase year-over-year.
  • IQVIA HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2025 was $247.00M, a 19.90% increase from fiscal 2024.
  • IQVIA HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $206.00M, a 5.07% decline from fiscal 2023.
  • IQVIA HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $217.00M, a 11.86% increase from fiscal 2022.
  • IQVIA HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2022 was $194.00M, a 14.12% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-03-31$65.00M
10-Q · filed 2026-05-05
$125.00M
derived: sum of 2 quarters · filed 2026-05-05
$180.00M
derived: sum of 3 quarters · filed 2026-05-05
$240.00M
derived: sum of 4 quarters · filed 2026-05-05
2025-12-31$60.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$115.00M
derived: sum of 2 quarters · filed 2026-02-17
$175.00M
derived: sum of 3 quarters · filed 2026-02-17
$247.00M
10-K · filed 2026-02-17
2025-09-30$55.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$115.00M
derived: sum of 2 quarters · filed 2025-10-28
$187.00M
10-Q · filed 2025-10-28
$235.00M
derived: sum of 4 quarters · filed 2026-05-05
2025-06-30$60.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22
$132.00M
10-Q · filed 2025-07-22
$180.00M
derived: sum of 3 quarters · filed 2026-05-05
$234.00M
derived: sum of 4 quarters · filed 2026-05-05
2025-03-31$72.00M
10-Q · filed 2026-05-05
$120.00M
derived: sum of 2 quarters · filed 2026-05-05
$174.00M
derived: sum of 3 quarters · filed 2026-05-05
$222.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$48.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$102.00M
derived: sum of 2 quarters · filed 2026-02-17
$150.00M
derived: sum of 3 quarters · filed 2026-02-17
$206.00M
10-K · filed 2026-02-17
2024-09-30$54.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$102.00M
derived: sum of 2 quarters · filed 2025-10-28
$158.00M
10-Q · filed 2025-10-28
$203.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-06-30$48.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22
$104.00M
10-Q · filed 2025-07-22
$149.00M
derived: sum of 3 quarters · filed 2026-02-17
$196.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-03-31$56.00M
10-Q · filed 2025-05-06
$101.00M
derived: sum of 2 quarters · filed 2026-02-17
$148.00M
derived: sum of 3 quarters · filed 2026-02-17
$198.00M
derived: sum of 4 quarters · filed 2026-02-17
2023-12-31$45.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$92.00M
derived: sum of 2 quarters · filed 2026-02-17
$142.00M
derived: sum of 3 quarters · filed 2026-02-17
$217.00M
10-K · filed 2026-02-17
2023-09-30$47.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$97.00M
derived: sum of 2 quarters · filed 2024-10-31
$172.00M
10-Q · filed 2024-10-31
$230.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$50.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22
$125.00M
10-Q · filed 2024-07-22
$183.00M
derived: sum of 3 quarters · filed 2025-02-13
$244.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$75.00M
10-Q · filed 2024-05-02
$133.00M
derived: sum of 2 quarters · filed 2025-02-13
$194.00M
derived: sum of 3 quarters · filed 2025-02-13
$239.00M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$58.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$119.00M
derived: sum of 2 quarters · filed 2025-02-13
$164.00M
derived: sum of 3 quarters · filed 2025-02-13
$194.00M
10-K · filed 2025-02-13
2022-09-30$61.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$106.00M
derived: sum of 2 quarters · filed 2023-11-01
$136.00M
10-Q · filed 2023-11-01
$178.00M
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30$45.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$75.00M
10-Q · filed 2023-08-01
$117.00M
derived: sum of 3 quarters · filed 2024-02-15
$165.00M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31$30.00M
10-Q · filed 2023-04-28
$72.00M
derived: sum of 2 quarters · filed 2024-02-15
$120.00M
derived: sum of 3 quarters · filed 2024-02-15
$168.00M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31$42.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
$90.00M
derived: sum of 2 quarters · filed 2024-02-15
$138.00M
derived: sum of 3 quarters · filed 2024-02-15
$170.00M
10-K · filed 2024-02-15
2021-09-30$48.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
$96.00M
derived: sum of 2 quarters · filed 2022-10-27
$128.00M
10-Q · filed 2022-10-27
$154.00M
derived: sum of 4 quarters · filed 2023-02-15
2021-06-30$48.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22
$80.00M
10-Q · filed 2022-07-22
$106.00M
derived: sum of 3 quarters · filed 2023-02-15
$139.00M
derived: sum of 4 quarters · filed 2023-02-15
2021-03-31$32.00M
10-Q · filed 2022-04-28
$58.00M
derived: sum of 2 quarters · filed 2023-02-15
$91.00M
derived: sum of 3 quarters · filed 2023-02-15
$127.00M
derived: sum of 4 quarters · filed 2023-02-15
2020-12-31$26.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15
$59.00M
derived: sum of 2 quarters · filed 2023-02-15
$95.00M
derived: sum of 3 quarters · filed 2023-02-15
$95.00M
10-K · filed 2023-02-15
2020-09-30$33.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22
$69.00M
derived: sum of 2 quarters · filed 2021-10-22
$69.00M
10-Q · filed 2021-10-22
$128.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30$36.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
$36.00M
10-Q · filed 2021-07-28
$95.00M
derived: sum of 3 quarters · filed 2022-02-16
$122.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31$0.00
10-Q · filed 2021-04-23
$59.00M
derived: sum of 2 quarters · filed 2022-02-16
$86.00M
derived: sum of 3 quarters · filed 2022-02-16
$120.00M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31$59.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$86.00M
derived: sum of 2 quarters · filed 2022-02-16
$120.00M
derived: sum of 3 quarters · filed 2022-02-16
$146.00M
10-K · filed 2022-02-16
2019-09-30$27.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22
$61.00M
derived: sum of 2 quarters · filed 2020-10-22
$87.00M
10-Q · filed 2020-10-22
$122.00M
derived: sum of 4 quarters · filed 2021-02-12
2019-06-30$34.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23
$60.00M
10-Q · filed 2020-07-23
$95.00M
derived: sum of 3 quarters · filed 2021-02-12
$126.00M
derived: sum of 4 quarters · filed 2021-02-12
2019-03-31$26.00M
10-Q · filed 2020-04-30
$61.00M
derived: sum of 2 quarters · filed 2021-02-12
$92.00M
derived: sum of 3 quarters · filed 2021-02-12
$118.00M
derived: sum of 4 quarters · filed 2021-02-12
2018-12-31$35.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12
$66.00M
derived: sum of 2 quarters · filed 2021-02-12
$92.00M
derived: sum of 3 quarters · filed 2021-02-12
$113.00M
10-K · filed 2021-02-12
2018-09-30$31.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01
$57.00M
derived: sum of 2 quarters · filed 2019-11-01
$78.00M
10-Q · filed 2019-11-01
$102.00M
derived: sum of 4 quarters · filed 2020-02-18
2018-06-30$26.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
$47.00M
10-Q · filed 2019-07-24
$71.00M
derived: sum of 3 quarters · filed 2020-02-18
$100.00M
derived: sum of 4 quarters · filed 2020-02-18
2018-03-31$21.00M
10-Q · filed 2019-05-02
$45.00M
derived: sum of 2 quarters · filed 2020-02-18
$74.00M
derived: sum of 3 quarters · filed 2020-02-18
$101.00M
derived: sum of 4 quarters · filed 2020-02-18
2017-12-31$24.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18
$53.00M
derived: sum of 2 quarters · filed 2020-02-18
$80.00M
derived: sum of 3 quarters · filed 2020-02-18
$106.00M
10-K · filed 2020-02-18
2017-09-30$29.00M
10-Q · filed 2017-10-27
$56.00M
derived: sum of 2 quarters · filed 2017-10-27
$82.00M
10-Q · filed 2018-10-25
$154.00M
derived: sum of 4 quarters · filed 2020-02-18
2017-06-30$27.00M
10-Q · filed 2017-08-04
$53.00M
10-Q · filed 2018-07-27
$125.00M
derived: sum of 3 quarters · filed 2020-02-18
$141.00M
derived: sum of 4 quarters · filed 2020-02-18
2017-03-31$26.00M
10-Q · filed 2018-05-04
$98.00M
derived: sum of 2 quarters · filed 2020-02-18
$114.00M
derived: sum of 3 quarters · filed 2020-02-18
$124.00M
derived: sum of 4 quarters · filed 2020-02-18
2016-12-31$72.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18
$88.00M
derived: sum of 2 quarters · filed 2020-02-18
$98.00M
derived: sum of 3 quarters · filed 2020-02-18
$106.00M
10-K · filed 2020-02-18
$80.00M
10-K · filed 2017-02-16
2016-09-30$16.00M
10-Q · filed 2017-10-27
$15.60M
10-Q · filed 2016-11-03
$26.00M
derived: sum of 2 quarters · filed 2017-10-27
$34.00M
10-Q · filed 2017-10-27
$34.36M
10-Q · filed 2016-11-03
$44.30M
derived: sum of 4 quarters · filed 2018-02-16
2016-06-30$10.00M
10-Q · filed 2017-08-04
$10.10M
10-Q · filed 2016-07-27
$19.00M
10-Q · filed 2017-08-04
$18.77M
10-Q · filed 2016-07-27
$28.30M
derived: sum of 3 quarters · filed 2018-02-16
$36.70M
derived: sum of 4 quarters · filed 2018-02-16
2016-03-31$9.00M
10-Q · filed 2017-05-08
$8.69M
10-Q · filed 2016-05-03
$18.30M
derived: sum of 2 quarters · filed 2018-02-16
$26.70M
derived: sum of 3 quarters · filed 2018-02-16
$37.40M
derived: sum of 4 quarters · filed 2018-02-16
2015-12-31$9.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
$17.70M
derived: sum of 2 quarters · filed 2018-02-16
$28.40M
derived: sum of 3 quarters · filed 2018-02-16
$38.00M
10-K · filed 2018-02-16
$37.76M
10-K · filed 2016-02-11
2015-09-30$8.40M
10-Q · filed 2016-11-03
$19.10M
derived: sum of 2 quarters · filed 2016-11-03
$28.70M
10-Q · filed 2016-11-03
$36.29M
derived: sum of 4 quarters · filed 2017-02-16
2015-06-30$10.70M
10-Q · filed 2016-07-27
$20.32M
10-Q · filed 2016-07-27
$27.89M
derived: sum of 3 quarters · filed 2017-02-16
$34.69M
derived: sum of 4 quarters · filed 2017-02-16
2015-03-31$9.57M
10-Q · filed 2016-05-03
$17.19M
derived: sum of 2 quarters · filed 2017-02-16
$23.99M
derived: sum of 3 quarters · filed 2017-02-16
$32.39M
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31$7.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
$14.41M
derived: sum of 2 quarters · filed 2017-02-16
$22.81M
derived: sum of 3 quarters · filed 2017-02-16
$30.00M
10-K · filed 2017-02-16
$30.00M
10-K · filed 2015-02-12
2014-09-30$6.80M
10-Q · filed 2015-10-28
$15.20M
derived: sum of 2 quarters · filed 2015-10-28
$22.39M
10-Q · filed 2015-10-28
$28.29M
derived: sum of 4 quarters · filed 2016-02-11
2014-06-30$8.40M
10-Q · filed 2015-07-29
$15.60M
10-Q · filed 2015-07-29
$21.49M
derived: sum of 3 quarters · filed 2016-02-11
$27.39M
derived: sum of 4 quarters · filed 2016-02-11
2014-03-31$7.22M
10-Q · filed 2015-04-29
$13.09M
derived: sum of 2 quarters · filed 2016-02-11
$18.99M
derived: sum of 3 quarters · filed 2016-02-11
$25.59M
derived: sum of 4 quarters · filed 2016-02-11
2013-12-31$5.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11
$11.77M
derived: sum of 2 quarters · filed 2016-02-11
$18.37M
derived: sum of 3 quarters · filed 2016-02-11
$22.83M
10-K · filed 2016-02-11
2013-09-30$5.90M
10-Q · filed 2014-10-30
$5.87M
10-Q · filed 2013-10-31
$12.50M
derived: sum of 2 quarters · filed 2014-10-30
$16.96M
10-Q · filed 2014-10-30
$29.17M
derived: sum of 4 quarters · filed 2015-02-12
2013-06-30$6.60M
10-Q · filed 2014-07-31
$6.62M
10-Q · filed 2013-08-01
$11.09M
10-Q · filed 2014-07-31
$23.27M
derived: sum of 3 quarters · filed 2015-02-12
$26.53M
derived: sum of 4 quarters · filed 2015-02-12
2013-03-31$4.47M
10-Q · filed 2014-05-01
$16.67M
derived: sum of 2 quarters · filed 2015-02-12
$19.93M
derived: sum of 3 quarters · filed 2015-02-12
$23.01M
derived: sum of 4 quarters · filed 2015-02-12
2012-12-31$12.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12
$15.46M
derived: sum of 2 quarters · filed 2015-02-12
$18.54M
derived: sum of 3 quarters · filed 2015-02-12
$25.93M
10-K · filed 2015-02-12
2012-09-30$3.26M
10-Q · filed 2013-10-31
$6.34M
derived: sum of 2 quarters · filed 2013-10-31
$13.73M
10-Q · filed 2013-10-31
2012-06-30$3.08M
10-Q · filed 2013-08-01
$10.47M
10-Q · filed 2013-08-01
2012-03-31$7.39M
10-Q · filed 2013-05-14
2011-12-31$14.13M
10-K · filed 2014-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
INCYTE CORP (INCY)United States$24.855B13.14
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B